Shiroh Onodera, Ph.D., joined the faculty of NYMC in 2016. Prior to joining the College, Dr. Onodera was recruited by the University of Pittsburgh, the University of Alberta (Edmonton, Canada), and the Public Health Research Institute at UMDNJ. Dr. Onodera works on the development of an Influenza B candidate vaccine virus, genomic packaging, recombination, and reverse genetics of Bacteriophage phi6, and many others.
Education
- Ph.D., Virology, Tohoku University in Sendai, Japan
Areas of Expertise
- Development of Influenza B Candidate Vaccine Viruses
- Genomic Packaging, Recombination, and Reverse Genetics of Bacteriophage phi6
Publications
- Kitahara S, Ando S, Uemura M, et. al. "ABCC6 pathogenic variants are associated with hemorrhagic phenotypes in Japanese patients with severe cerebral small vessel disease." Scientific reports, (), (2026) . doi: 10.1038/s41598-025-33934-3
- Sun XN, Funcke JB, Joung C, et. al. "Neuronal GPR75 deficiency protects against diet-induced obesity in a humanized mouse model." Science advances, 12(4), (2026) eady7993. doi: 10.1126/sciadv.ady7993
- Chen W, Kaigawa T, Yokose J, et. al. "Teneurin-4 in the nucleus accumbens modulates affective-like behaviors with potential effects on astrocytes in male mice." Biochemical and biophysical research communications, 801(), (2026) 153309. doi: 10.1016/j.bbrc.2026.153309
- Yamaoka H, Tanida H, Schwier EF, et. al. "Itinerant to Localized Heavy Electron Magnetism in Ce(Ru_{1-x}Rh_{x})_{2}Al_{10}: A Direction-Dependent Phase Diagram beyond the Doniach Phase Diagram." Physical review letters, 135(26), (2025) 266503. doi: 10.1103/hdcf-dycj
- Maeda K, Hirunagi T, Sahashi K, et. al. "An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment." Molecular therapy. Nucleic acids, 37(1), (2025) 102802. doi: 10.1016/j.omtn.2025.102802
- Onodera S, Sue S, Kaneko H, et. al. "Risk factors for gastric cancer diagnosed more than 10 years after eradication therapy of Helicobacter pylori." Scandinavian journal of gastroenterology, (), (2026) 1-10. doi: 10.1080/00365521.2026.2615406
- Sakurai M, Arai Y, Goto H, et. al. "Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registry." Cytotherapy, 28(3), (2025) 102042. doi: 10.1016/j.jcyt.2025.102042
Teaching Responsibilities
- Microbiology
